APA (7th ed.) Citation

Krecic-Shepard, M. E., Barnas, C. R., Slimko, J., Gorski, J. C., Wainer, I. W., & Schwartz, J. B. (1999). In vivo comparison of putative probes of CYP3A4/5 activity: Erythromycin, dextromethorphan, and verapamil. Clinical pharmacology and therapeutics, 66(1), 40. https://doi.org/10.1016/s0009-9236(99)70052-4

Chicago Style (17th ed.) Citation

Krecic-Shepard, M E., C R. Barnas, J. Slimko, J C. Gorski, I W. Wainer, and J B. Schwartz. "In Vivo Comparison of Putative Probes of CYP3A4/5 Activity: Erythromycin, Dextromethorphan, and Verapamil." Clinical Pharmacology and Therapeutics 66, no. 1 (1999): 40. https://doi.org/10.1016/s0009-9236(99)70052-4.

MLA (9th ed.) Citation

Krecic-Shepard, M E., et al. "In Vivo Comparison of Putative Probes of CYP3A4/5 Activity: Erythromycin, Dextromethorphan, and Verapamil." Clinical Pharmacology and Therapeutics, vol. 66, no. 1, 1999, p. 40, https://doi.org/10.1016/s0009-9236(99)70052-4.